Anders Frid (Former)

21 – 30 of 44

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/endo-afr?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2009
Mark Sensor augmented pump therapy substantially lowers HbA(1c); a randomized controlled trial
Hermanides, J. ; Norgaard, K. ; Bruttomesso, D. ; Mathieu, C. ; Frid, Anders ^LU ; Dayan, C. M. ; Diem, P. ; Fermon, C. ; Wentholt, I. M. E. and Hoekstra, J. B. L. , et al. (2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.90-90
- Contribution to journal › Published meeting abstract
Mark Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
Nauck, Michael ; Frid, Anders ^LU ; Hermansen, Kjeld ; Shah, Nalini S. ; Tankova, Tsvetalina ; Mitha, Ismail H. ; Zdravkovic, Milan ; During, Maria and Matthews, David R. (2009) 68th Annual Meeting of the American-Diabetes-Association 32(1). p.84-90
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
Mark Metformin i serum. Studieresultat ger grund för preliminära behandlingsrekomendationer.
Frid, Anders ^LU ; Sterner, Gunnar ^LU ; Löndahl, Magnus ^LU ; Vinge, Ellen ^LU ; Cato, Anne and Andersson, Anders S ^LU (2009) In Läkartidningen 106(7). p.428-429
- Contribution to journal › Article
2008
Mark Liraglutide, a once-daily human GLP-1 analogue, in type 2 diabetes provides similar glycaemic control with reduced body weight compared with glimepiride when added to metformin
Hermansen, K. ; Nauck, M. A. ; Frid, Anders ^LU ; Shah, N. S. ; Tankova, T. ; Mitha, I. H. ; During, M. ; Zdravkovic, M. and Matthews, D. (2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.358-358
- Contribution to journal › Published meeting abstract
Mark Beliefs about health and illness in women managed for gestational diabetes in two organisations.
Hjelm, Katarina ; Berntorp, Kerstin ^LU ; Frid, Anders ^LU ; Åberg, Anders E ^LU and Apelqvist, Jan ^LU (2008) In Midwifery 24. p.168-182
- Contribution to journal › Article
Mark The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat
Jendle, J. ; Nauck, M. A. ; Matthews, D. ; Frid, Anders ^LU ; Hermansen, K. ; During, M. ; Zdravkovic, M. ; Strauss, B. and Garber, A. (2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.318-318
- Contribution to journal › Published meeting abstract
Mark Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes What to add-Insulin glargine or pioglitazone?
Dorkhan, Mozhgan ^LU ; Frid, Anders ^LU and Groop, Leif ^LU (2008) In Diabetes Research and Clinical Practice 82. p.340-345
- Contribution to journal › Article
2007
Mark A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.
Dorkhan, Mozhgan ^LU and Frid, Anders ^LU (2007) In Vascular Health and Risk Management 3(5). p.721-731
- Contribution to journal › Scientific review
Mark A simplified oral glucose tolerance test in pregnancy: compliance and results.
Anderberg, Eva ^LU ; Källén, Karin ^LU ; Berntorp, Kerstin ^LU ; Frid, Anders ^LU and Åberg, Anders E ^LU (2007) In Acta Obstetricia et Gynecologica Scandinavica 86. p.1432-1436
- Contribution to journal › Article
2006
Mark Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.
Dorkhan, Mozhgan ^LU ; Lantz, Mikael ^LU ; Frid, Anders ^LU ; Groop, Leif ^LU and Hallengren, Bengt ^LU (2006) In Clinical Endocrinology 65(1). p.35-39
- Contribution to journal › Article